OR WAIT 15 SECS
Research is shedding light on the mysteries of this distressing disorder, which isn&t as rare as you might think. Once the diagnosis is made, antiemetic and antimigraine drugs provide reasonably effective relief.
|Jump to:||Choose article section...LEARNING OBJECTIVES What is CVS? How common is CVS? Who is affected? Why are many cases of CVS missed? What are the clinical clues? How is CVS diagnosed? What tests should be done? What is the natural history of CVS? Do CVS and migraine overlap?How is CVS treated? When should you refer? A decade of progress|
Research is shedding light on the mysteries of this distressing disorder, which isn't as rare as you might think. Once the diagnosis is made, antiemetic and antimigraine drugs provide reasonably effective relief.
Cyclic vomiting syndrome (CVS) is characterized by recurrent stereotypical spells of vomiting between which the child is completely well. For nearly two centuries, since the disorder was first described, its cause and pathophysiology have remained unknown.1,2 Over the past decade, however, some light has emerged from the darkness (see "Pursuing the pathophysiology of CVS"). Pediatric gastroenterologists have doubled the number of relevant publications and assembled an interdisciplinary team to begin translational (bench-to-bedside) research into the mechanisms of and effective therapy for this disorder.3
After reviewing this article the physician should be able to:
The 21st century dawns with new hope for affected children and adolescents. Collaborative research promises improved understanding and evidence-based treatment of CVS, and an international support group, the Cyclic Vomiting Syndrome Association (with 29 international chapters), has been formed to help families cope with this disruptive disorder (for contact information, see below). We hope this article will help you diagnose CVS accurately and in a timely fashionthereby avoiding the delays that often occur when the condition is misdiagnosed as acute gastroenteritis, gastroesophageal reflux, food poisoning, or psychogenic vomitingso that your patients can get the treatment and support they need.
In 1882, Samuel Gee identified the three essential clinical features of CVS that form the core of the consensus diagnostic criteria established in 1994 (Table 1):1,4
Recurrent severe, discrete episodes of vomiting
Varying intervals of normal health between episodes
Duration of vomiting episodes from hours to days
No apparent cause of vomiting (negative laboratory, radiographic, and endoscopic testing)
Stereotypical: Each episode similar as to time of onset, intensity, duration, frequency, associated symptoms and signs within individuals
Self-limited: Episodes resolve spontaneously if left untreated
Nausea, abdominal pain, headache, motion sickness, photophobia (+ lethargy)
Fever, pallor, diarrhea, dehydration, excess salivation, social withdrawal
Source: The International Scientific Symposium on Cyclic Vomiting Syndrome4
To these features, we have added a fourth criterion: absence of laboratory findings that point to a specific cause of vomiting.
When seen in the office between episodes, the child with CVS is asymptomatic and appears so normal that the history of repetitive bouts of relentless vomiting and dehydration can be difficult to believe. Although the typical child spends 90% of the time well, we have documented substantial annual morbidity and medical costs: 20 missed days of school for each child, a high rate of IV rehydration (50% of children with CVS compared with fewer than 1% of patients with rotavirus), and more than $17,000 in costs for each family attributable to laboratory testing, imaging studies, endoscopic procedures, emergency room visits, hospitalizations, and missed work by parents.2
Although the prevalence of CVS in the United States has not been established, it can no longer be considered a rare disorder based on the available evidence. Two population surveys among Caucasian children in Scotland and Australia estimated the prevalence at 2%.5 In an informal survey of four-person pediatric practices, we found that between four and 12 cases per practice had been diagnosed. In our clinical experience, CVS causes one third of cases of recurrent vomiting in children older than 2 years. CVS occurs in all races, with a girl-to-boy ratio of 55:45. The median age of onset is 6 years, but the correct diagnosis is usually not made for 2.6 years. CVS can begin in infancy and is often difficult to differentiate from gastroesophageal (GE) reflux. We traced one case back to six days of age through hospital records that documented a recurrent nine-hour pattern of vomiting every 20 minutes. Although it appears to be primarily a disorder of childhood, CVS is more and more being diagnosed in adults.6 Prevalence in adults appears to be lower than in children, however.
We suspect that many cases of CVS are missed, judging from the fact that the apparent prevalence is much higher than the actual number of cases diagnosed. In our practice, we observed that the number of cases identified for each gastroenterologist rose from one to seven annually as awareness of the disorder increased.
In truth, any individual episode of CVS resembles a bout of acute gastroenteritis associated with dehydration. Episodes are also often labeled as food poisoning. Because different physiciansoffice-based pediatric partners, urgent care physicians, and emergency room doctorsmay evaluate individual vomiting episodes, the recurrent pattern often goes undetected. Once the pattern is recognized, labels such as GE reflux or psychogenic vomiting are often applied. It is usually the parents who first recognize, after multiple episodes, that the problem cannot be recurrent stomach flu.
An acute episode of CVS is commonly mistaken for a bout of viral gastroenteritis because of concomitant vomiting, low-grade fever (29%), and diarrhea (36%) (Table 2, available in the print issue, adapted from Li BUK: Cyclic vomiting: new understanding of an old disorder. Contemporary Pediatrics 1996;14(7):48).2,7 On closer examination, children with CVS appear substantially more ill than those with viral gastroenteritis. They vomit at a peak pace of every five to 10 minutes, an intensity unmatched by any other disorder.8 They can be so pale as to appear to be in shock and are often locked into a fetal position by unrelenting pain and nausea. Even before becoming dehydrated from fluid loss, they may become so listless that they cannot walk or talk and have to be carried everywhere.
The temporal pattern of vomiting in CVS is distinct from the chronic vomiting of GE reflux. Our study of the patterns found that they could be quantitatively differentiated (Figure 1, available in the print issue, adapted from Li BUK: Cyclic vomiting: new understanding of an old disorder. Contemporary Pediatrics 1996;14(7):48).8 Children with a cyclic pattern vomited at a peak of six to 13 times an hour, but only twice a month (high intensity, low frequency). Those with the chronic pattern vomited a maximum of one or two times an hour but nearly every day (low intensity, high frequency). By using the criteria of more than four emeses an hour at peak and fewer than two episodes a week, we were able to differentiate CVS from recurrent vomiting with greater than 92% sensitivity and specificity. Although "cyclic" implies stable periodicity (usually every two or four weeks), that pattern is in fact found among only half of children with CVS; the other half experience vomiting that is episodic but unpredictable in timing.
Besides vomiting, children with CVS suffer from severe anorexia, nausea, retching, and midline abdominal pain. Despite the purported relationship between CVS and migraine headaches, our study found classic migraine symptoms of headache, photophobia, phonophobia, and vertigo in fewer than half of patients. Migraine-associated symptoms, however, were found in significantly higher percentages than among a comparison group with chronic vomiting or case controlsunderscoring the suspected relationship between CVS and migraine.9,10
CVS episodes can happen at any time but tend to occur consistently around the same time of day in a given patient, most often in the early morning hourseither between 2 a.m. and 4 a.m. or upon awakening between 6 a.m. and 7 a.m.7,8 Parents often describe the episodes as beginning and ending abruptly. When documented, the prodromal periodsome combination of pallor, anorexia, nausea, abdominal pain, and lethargy but not teichopsia (a sensation of luminosity before the eyes)and the recovery period (from the point of last emesis to eating and being playful) are both relatively brief: 30 minutes and 5 hours, respectively.
When asked, two thirds of parents can identify life events that appear to trigger the episodes. Two types of stressorsinfectious and psychologicalpredominate.2,7,10 The infections include common respiratory infections, the most frequent being confirmed chronic sinusitis. The psychological stresses are as likely to be positive excitement (birthdays, holidays, vacations) as negative stressors related to school (exams) or family (divorce). Other triggers include foods (chocolate, cheese, and monosodium glutamate), food or inhalant allergies, physical exhaustion, motion (car rides), anesthesia, and menses in postmenarchal girls.
Three questions are essential to make a tentative diagnosis of CVS:
If you ask simply whether the child has had previous similar bouts of "stomach flu" or vomiting, and the response is five or six episodes over the past few months, consider CVS. Other supporting evidence includes vomiting frequency greater than every 15 minutes at peak (71% of patients), associated symptoms of pallor (91%), lethargy (87%), abdominal pain (80%), retching (78%), anorexia (74%), and nausea (72%), as well as a positive family history of migraine (82%).
If the three main criteria are met, the child clearly has a cyclic vomiting pattern that is compatible with CVS. Laboratory testing is currently required, however, to exclude serious disorders that can present with recurrent episodic vomiting (see "Disorders that mimic CVS," below). Once testing is completed with negative results, the child can be given a diagnosis of idiopathic CVS.
CVS remains a diagnosis made by both historical criteria and absence of laboratory findings that support an alternate diagnosis. Yet how much testing is required to exclude the many potential underlying disorders remains open.11 One in eight patients (12%) with the cyclic vomiting pattern is found to have a specific underlying disorder that requires intervention. Costly lawsuits have resulted from missed diagnoses, especially malrotation with volvulus, which can lead to complications that include small bowel resection and long-term parenteral nutrition.
The complete evaluation includes standard blood work (glucose, electrolytes, alanine transaminase [ALT],
-glutamyl transpeptidase [GGTP], amylase, lipase, urinalysis) and metabolic screening (lactate, ammonia, amino acids and urine organic acids,
-ALA, and porphobilinogen) during the episode, small bowel radiography, abdominal ultrasonography, magnetic resonance imaging or computed tomography scan of the head and sinuses, and endoscopy (Table 3, available in the print edition, adapted from Li BUK, Balint JP and LiBuk: Cyclic Vomiting: New understanding of an old disorder. Contemporary Pediatrics 1996;17(7):48). The main red flags in the initial evaluation that impel us to do additional testing include severe headaches, GI bleeding, unilateral abdominal pain, weight loss, failure to respond to any treatment, progressive worsening, prolonged episodes requiring repeated hospitalizations, and a change in pattern or symptoms.
The fact that migraine-associated CVS (CVS with a family history of migraine) is found in 82% of patients and is likely to respond to antimigraine therapy (79%) suggests that a short-term empiric antimigraine trial could potentially precede diagnostic testing.9 A recent cost analysis found that an initial approach comprising small intestinal radiography to exclude malrotation plus an empiric two-month antimigraine trial was more beneficial than the standard approach of complete metabolic, radiographic, and endoscopic testing before any treatment.12 That strategy cannot be definitively recommended until tested prospectively, however.
The good news is that most children appear to outgrow CVS with advancing age, most often during the preteen or early teenage years.13 In our series, the median ages at onset, diagnosis, and resolution were 5, 8, and 10 years.2 The time from onset of symptoms to accurate diagnosis was 2.6 years. The average child experienced 22 vomiting episodes over three and a half years. The age at resolution among the children in our series, 10 years, is probably lower than the actual age because our series is biased toward children in whom CVS has ended early; it will likely rise with longer follow-up.
The bad news is that many children trade cyclic vomiting for migraine headaches at 10 years or older (Figure 2). So far, 28% of those in our study whose vomiting episodes have ended have developed migraine headaches, and we project that 75% will do so by 18 years of age.
The simple answer is "Yes." Strong circumstantial evidence points to substantial clinical overlap between CVS, abdominal migraine, and migraine headache.9,10,14,15 Some of the evidence is as follows. A positive family history of migraine is strongly associated with CVS, but not with chronic vomiting (82% vs. 14%).2,8 Nearly 75% of children with CVS, abdominal migraine, or migraine headache share associated symptoms of pallor, anorexia, and nausea. From the natural history, we know that CVS can evolve into migraine headaches. Perhaps most compelling, both CVS and abdominal migraine frequently respond to antimigraine headache therapy. It appears that CVS, abdominal migraine, and migraine headaches may represent three age-dependent phases of migraine.
How does one differentiate CVS and abdominal migraine when so many symptoms overlap (Table 4, available in the print edition, adapted from Li BUK, Balint JP: Cyclic vomiting syndrome: Evolution in understanding of a brain-gut disorder. Adv Pediatr 2000;47:117)? It depends on the predominant or most consistent primary symptom, whether vomiting, abdominal pain, or headachecorresponding to CVS, abdominal migraine, and migraine headache, respectively.2 Even then, nearly 80% of children with CVS can be given a diagnosis of abdominal migraine interchangeably, and 50% of those with abdominal migraine can be given a diagnosis of CVS concomitantly.
Although no established therapy for CVS has been proven efficacious in controlled trials, reasonably effective empiric treatments have been identified based on clinical experience and open trials.2,7 Our approach is to provide supportive care during acute episodes. This includes admitting the child to a quiet, dark hospital room to avoid overstimulation that can trigger further nausea and vomiting, giving IV fluids to replace losses, administering sedation to reduce nausea, and, occasionally, giving an analgesic.16
Pharmacologic treatment includes abortive medications, administered at the onset of the episode to break the attack, and prophylactic agents, given daily to prevent attacks (Table 5, available in the print edition, adapted from Li BUK, Balint JP: Cyclic vomiting syndrome: Evolution in understanding of a brain-gut disorder. Adv Pediatr 2000;47:117). The efficacy of these agents has been difficult to establish because of the absence of controlled trials and a high placebo responsegreater than 50%.17 Treatment is based on three variables: family history of migraine, frequency of episodes, and severity of episodes. If there is a family history of migraine, we start antimigraine therapy. If episodes occur more than once every four weeks or are severe or prolonged (requiring hospitalization lasting longer than two days), we give prophylactic therapy daily. If episodes occur less often than once a month or are relatively mild, we usually try abortive therapy at the onset of the episode. If abortive therapy fails, we resort to prophylactic therapy.
No established hierarchy of medications exists for treating CVS. We therefore recommend medications whose dose titration and side effects you are familiar with. In the abortive category, 5-HT3 antagonists such as ondansetron and antimigraine triptans such as sumatriptan are effective in more than half of children when given parenterally or nasally, respectively. Oral doses are, as would be expected, ineffective because they cannot be kept down.
In the prophylactic category, antimigraine agents (propranolol, cyproheptadine, and amitriptyline) are most widely used, but anticonvulsant (phenobarbital) and prokinetic (erythromycin) medications have also proved successful.16-20
Medications that may become available for use include new antimigraine triptans, anticonvulsants (gabapentin and topamirate), tachykinin receptor antagonists (potential antiemetics in animal studies), and corticotropin-releasing factor antagonists (to truncate the stress response).
Once the cyclic vomiting pattern has been identified, the next step is to perform exclusionary radiographic and laboratory testing to either establish the diagnosis of CVS or identify a specific underlying disorder. Once screening tests are completed, the child can be started on an empiric trial of medication. Depending on your comfort level, some form of prophylactic antimigraine therapy is reasonable. Referral to a pediatric gastroenterologist, neurologist, or metabolic specialist who is familiar with the disorder is recommended:
The subspecialist would pursue further testing and try other medications, such as triptans and anticonvulsants, which are used off label to treat CVS. For difficult and refractory cases, we have started a Cyclic Vomiting Center at Children's Memorial Hospital in Chicago for tertiary and quaternary evaluations.
Parents of children with CVS are understandably frustrated by the recurrent yet unpredictable episodes that control and disrupt their family's life. Lack of a diagnosis and lack of physician understanding of the disorder compound the frustration. The Cyclic Vomiting Syndrome Associationa national and international organization that offers phone support, support groups, regional conferences, a newsletter, a Web site, and a bulletin boardhas proved immensely helpful to patients and their families.
Although CVS remains mysterious, substantial progress in understanding its clinical patterns and potential mechanisms has been made over the past decade. The clinical pattern is one of stereotypical, explosive episodes of vomiting punctuating periods of completely normal health. In addition to the possible involvement of migraine mechanisms, pathophysiologic attention has focused on mitochondrial DNA mutations causing cellular energy deficit and corticotropin-releasing factor as a mediator of vagally mediated emesis.
Although CVS can no longer be regarded as a rare disorder, it is still often misdiagnosed as gastroenteritis, gastroesophageal reflux, food poisoning, and psychogenic vomiting. Because many serious diseases mimic CVS, excluding disorders that involve the digestive, central nervous, renal, metabolic, and endocrine systems remains a key clinical approach. Although treatment remains empiric, antimigraine and antiemetic agents are reasonably effective.
1. Gee S: On fitful or recurrent vomiting. St Bart Hosp Rep 1882;18:1
2. Li BUK, Balint JP: Cyclic vomiting syndrome: Evolution in understanding of a brain-gut disorder. Adv Pediatr 2000;47:117
3. Li BUK, Issenman R, Sarna S (eds): Proceedings of the 2nd International Symposium on Cyclic Vomiting Syndrome. Dig Dis Sci 1999;44 (suppl):1S
4. Li BUK (ed): Proceedings of the International Symposium on Cyclic Vomiting Syndrome. J Pediatr Gastroenterol Nutr 1995;21(suppl):S1
5. Abu-Arafeh I, Russell G: Cyclic vomiting syndrome in children: A population-based study. J Pediatr Gastroenterol Nutr 1995;21:454
6. Prakash C, Clouse RE: Cyclic vomiting syndrome in adults: Clinical features and response to tricyclic antidepressants. Am J Gastroenterol 1999;94:2855
7. Fleisher DR, Matar M: Cyclic vomiting syndrome: A report of 71 cases and literature review. J Pediatr Gastroenterol Nutr 1993:17:361
8. Pfau BT, Li BUK, Murray RD, et al: Differentiating cyclic from chronic vomiting patterns in children: Quantitative criteria and diagnostic implications. Pediatrics 1996:97:364
9. Li BUK, Murray RD, Heitlinger LA, et al: Is cyclic vomiting syndrome related to migraines? J Pediatr 1999:134:567
10. Withers GD, Silburn SR, Forbes DA: CVS: A descriptive analysis of symptoms, precipitants, aetiology and treatment. Acta Paediatr 1998;87:272
11. Li BUK, Murray RD, Heitlinger LA, et al: Heterogeneity of diagnoses presenting as cyclic vomiting. Pediatrics 1998;102:583
12. Olson AD, Li BUK: The diagnostic evaluation of children with cyclic vomiting: A cost effectiveness analysis. J Pediatr (in press)
13. Hoyt CS, Stickler GB: A study of 44 children with the syndrome of recurrent (cyclic) vomiting. Pediatrics 1960;25:775
14. Lanzi G, Ballotin U, Ottolini F, et al: Cyclic vomiting and recurrent abdominal pains as migraine or epileptic equivalents. Cephalalgia 1983;3:115
15. Symon D, Russell G: Abdominal migraine: A childhood syndrome defined. Cephalalgia 1986;6:223
16. Li BUK: Current treatment of cyclic vomiting syndrome. Current Treatment Options in Gastroenterology 2000:3:395
17. Fleisher DR: Cyclic vomiting syndrome, in Hyman PE, DiLorenzo C (eds): Pediatric GI Motility Disorders. NY, Academy Professional Information Services, Inc, 1994, pp 89104
18. Andersen JM, Sugerman KS, Lockhart JR, et al: Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 1997;100:977
19. Gokhale R, Huttenlocher PR, Brady L, et al: Use of barbiturates in the treatment of cyclic vomiting during childhood. J Pediatr Gastroenterol Nutr 1997; 25:64
20. Vanderhoof JA, Young R, Kaufman SS, et al: Treatment of cyclic vomiting in childhood with erythromycin. J Pediatr Gastroenterol Nutr 1993;17: 387
Despite the fact that CVS has a well-characterized pattern of stereotypical, severe episodes of vomiting, we now suspect that it is a heterogeneous group of disorders rather than a single disorder. Several lines of evidence point in this direction. First, we know that vomiting can be caused by a variety of disorders that affect many different systems. Second, CVS appears to include several clinical subgroupsmigraine and nonmigraine, for examplethat show significant differences in vomiting episodes and response to antimigraine agents. Third, several distinct pathways (migraine, stress activation, energy deficit) can now be defined based on studies in animals and humans.
Because there is clear overlap between CVS and migraine, similar electrophysiological and cerebrovascular events may underlie both conditions. It also appears that increased autonomic sympathetic tone may enhance susceptibility to both CVS and migraine headaches.1 Mitochondrial energy production seems to be involved in some patients. Mitochondrial encephalopathy, lactic acidosis, and stroke-like (MELAS) syndrome involves both cyclic vomiting and migraine headaches. Several new mutations in the mitochondrial DNA control region have been identified recently in children who have cyclic vomiting in association with episodic autonomic manifestations and lactic acidosis.2
A series of children with hypertension, elevated adrenocorticotropic hormone (ACTH), antidiuretic hormone (ADH), and stress hormones, described by Sato, are thought to have hypothalamic dysregulation.3 Because of extensive experimental evidence that corticotropin-releasing factor can induce gastric stasis and vomiting, we now suspect that it may be a key brain-gut mediator involved in CVS.4
Two additional pathophysiologic leads are worth mentioning. Identification of food sensitivity to cow's milk, soy, and egg white protein and demonstration of a clinical response to food elimination has been demonstrated recently.5 Also, in a phenomenon similar to menstrual migraine headaches, we have seen postmenarchal girls who develop catamenial CVS at the onset of their menstrual period. Most respond to treatment with a low-dose estrogen birth control pill.
1. To J, Issenman R, Kamath MV: Evaluation of neurocardiac signals in pediatrics patients with cyclic vomiting syndrome through power spectral analysis of heart rate variability. J Pediatr 1999;135:363
2. Boles RG, Chun N, Denadheera D, et al: Cyclic vomiting syndrome and mitochondrial DNA mutations. Lancet 1997;350:1299
3. Sato T, Igarashi M, Minami S, et al: Recurrent attacks of vomiting, hypertension, and psychotic depression: A syndrome of periodic catecholamine and prostaglandin discharge. Acta Endocrinol 1988;117:189
4. Taché Y: Cyclic vomiting syndrome: The corticotropin-releasing-factor hypothesis. Dig Dis Sci 1999; 44(suppl):79S
5. Lucarelli S, Corrado G, Pelliccia A, et al: Cyclic vomiting syndrome and food allergy/intolerance in 7 children. Eur J Pediatr 2000;159:360
Many disorders, including some serious surgical lesions, can mimic CVS. We studied the epidemiology of these disorders and lesions in 225 patients in our care who exhibited a pattern of cyclic vomiting.1 Overall, we found that one in eight had a specific underlying diagnosisnot CVS, that isand that one in nine had a surgical lesion. Neither organic disorders nor surgical lesions were, therefore, rare.
Underlying organic disorders that can mimic CVS affect four main systems: gastrointestinal (malrotation with volvulus), central nervous system (posterior fossa neoplasms), renal (acute hydronephrosis), and metabolic or endocrine (mitochondriopathies or Addison's disease). In our cohort of nearly 400 patients, we have seen five malrotations with suspected volvulus, five Chiari malformations, three brainstem gliomas and cerebellar medulloblastomas, and 10 hydronephroses with uteropelvic junction obstruction (so-called Dietl's crisis with flank pain) that required surgical correction. As we screen systematically, we find increasing numbers of cases of hydronephrosis from obstructive uropathy, mitochondriopathies associated with episodic autonomic symptoms and elevated lactic acidosis, and Sato's hypothalamic surge with hypertension and increased elevated adrenocorticotropic hormone (ACTH), antidiuretic hormone (ADH), cortisol, prostaglandin E2 (PGE2), and catecholamine levels.2
1. Li BUK, Murray RD, Heitlinger LA, et al: Heterogeneity of diagnoses presenting as cyclic vomiting. Pediatrics 1998;102:583
2. Sato T, Igarashi N, Minami S, et al : Recurrent attacks of vomiting, hypertension, and psychotic depression: A syndrome of periodic catecholamine and prostaglandin discharge. Acta Endocrinol 1988;117:189
Cyclic Vomiting Syndrome Association (CVSAUSA/Canada)
Debra Waites, Administrator
3585 Cedar Hill Rd., NW
Canal Winchester, OH 43110
Web site: www.cvsaonline.org
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Jefferson Medical College and Medical Economics, Inc.
Jefferson Medical College of Thomas Jefferson University, as a member of the Consortium for Academic Continuing Medical Education, is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. All faculty/authors participating in continuing medical education activities sponsored by Jefferson Medical College are expected to disclose to the activity audience any real or apparent conflict(s) of interest related to the content of their article(s). Full disclosure of these relationships, if any, appears with the author affiliations on page 1 of the article and below.
This CME activity is designed for practicing pediatricians and other health-care professionals as a review of the latest information in the field. Its goal is to increase participants' ability to prevent, diagnose, and treat important pediatric problems.
Jefferson Medical College designates this continuing medical educational activity for a maximum of one hour of Category 1 credit toward the Physician's Recognition Award (PRA) of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
This credit is available for the period of March 15, 2002, to March 15, 2003. Forms received after March 15, 2003, cannot be processed.
Although forms will be processed when received, certificates for CME credits will be issued every four months, in March, July, and November. Interim requests for certificates can be made by contacting the Jefferson Office of Continuing Medical Education at 215-955-6992.
1. Each CME article is prefaced by learning objectives for participants to use to determine if the article relates to their individual learning needs.
2. Read the article carefully, paying particular attention to the tables and other illustrative materials.
3. Complete the CME Registration and Evaluation Form on the following page. Type or print your full name and address in the space provided, and provide an evaluation of the activity as requested. In order for the form to be processed, all information must be complete and legible.
4. Send the completed form, with $15 payment, to: Office of Continuing Medical Education/JMC Jefferson Alumni Hall 1020 Locust St., Suite M32 Philadelphia, PA 19107-6799
Jefferson Medical College, in accordance with accreditation requirements, asks the authors of CME articles to disclose any affiliations or financial interests they may have in any organization that may have an interest in any part of their article. The following information was received from the author of "New hope for children with cyclic vomiting syndrome."
B U. K. Li, MD, has nothing to disclose.
Jennifer C. Howard, RN, has nothing to disclose.
Date of publication: March 2002
Title: "New hope for children with cyclic vomiting syndrome"
Authors: B U. K. Li, MD, and Jennifer C. Howard, RN
MP Code: CP0302
Name: _______________________________________________ Degree: _______________
Street address: ____________________________ Institutional affiliation: ______________
City: _____________________ State: __________ ZIP: ___________ Telephone: __________
Specialty: [ ] Pediatrics [ ] Other _________________ Years in practice: _________ Resident? ___
Time needed to complete this CME activity: [ ] <1 hr [ ] 1 hr [ ] 1.5 hr [ ] 2 hr
Certification: I attest to having completed this CME activity.
1. Rate the overall effectiveness of this CME activity. 5 (very effective) 4 3 2 1 (not at all effective)
2. Circle "Yes" or "No"
|Yes||No||A. The learning objectives were useful to me in determining whether performing this CME activity would be a worthwhile educational experience for me.|
|Yes||No||B. The objectives accurately described the content and potential learning value of this article.|
|Yes||No||C. This activity will influence how I practice medicine.|
|Yes||No||D. The activity was free from commercial bias.|
|Yes||No||E. I learned something new that was important from the article.|
3. Which of the following best describes a change you might consider making in your practice as a result of something you learned from this activity? (Please circle only one response.)
A. Slightly modify what I currently do.
B. Make a major change in what I currently do.
C. Follow a procedure; use a technique/technology that is completely new to me.
D. Follow a procedure; use a technique/technology that I currently use but for a different purpose.
E. None of the above, but some change.
F. Not considering any changes.
4. Please describe any change(s) you plan to make in your practice as a result of this activity: ________
5. How committed are you to making these changes? 5 (very committed) 4 3 2 1 (not at all committed)
6. Other comments __________________________________________________________________
I am enclosing $15 to cover the cost of processing my CME application.
[ ] I am enclosing a check (payable to JMC/CME).
[ ] Please charge my Mastercard or Visa (circle type of card),
Account number: ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___
Expiration date: ____ ____ / ____ ____.
B.U.K. Li, Jennifer Howard. CME: New hope for children with cyclic vomiting syndrome. Contemporary Pediatrics 2002;3:121.